Andrea Giacometti
Ancona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 82 publications
Severe Acute SARS-CoV-2 Infection and Long COVID: What Do We Know So Far? New Challenges in Diagnosis and Management.
Journal: Diseases (Basel, Switzerland)
Published: May 17, 2025
Ceftazidime-Avibactam in Critically Ill Patients: A Multicenter Observational Study.
Journal: Antibiotics (Basel, Switzerland)
Published: April 28, 2025
Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.
Journal: EClinicalMedicine
Published: March 31, 2025
In vitro activities of lipopeptides against fluconazole-resistant Candida auris.
Journal: Microbiology spectrum
Published: February 27, 2025
High Mortality and Antimicrobial Resistance: Challenges of Bloodstream Infections in Liver Transplant Recipients.
Journal: Le infezioni in medicina
Published: February 19, 2025
Clonal dissemination of Klebsiella pneumoniae carrying blaOXA-48 gene in a central Italy hospital.
Journal: Journal of global antimicrobial resistance
Published: September 22, 2023
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort.
Journal: United European gastroenterology journal
Published: August 13, 2023
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Journal: The Journal of antimicrobial chemotherapy
Published: July 02, 2023
Genomic Analysis of a Linezolid-Resistant Staphylococcus capitis Causing Bacteremia: Report from a University Hospital in Central Italy.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: May 24, 2023
The sources of antimicrobial peptides against Gram-positives and Gramnegatives: our research experience.
Journal: Le infezioni in medicina
Published: May 19, 2023
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study.
Journal: Journal of medical virology
Published: May 16, 2023
Real-life comparison of mortality in patients with SARS-CoV-2 infection at risk for clinical progression treated with molnupiravir or nirmatrelvir plus ritonavir during the Omicron era in Italy: a nationwide, cohort study.
Journal: The Lancet regional health. Europe
Published: May 09, 2023
Last Updated: 09/26/2026